Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 220 participants.

Also called NCT03049657

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 220 participants (enrolled count) (from the registry)
Sponsor
Cardiva2 S.L. (from the registry)
Registry
  • NCT NCT03049657
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03049657. Randomized; no masking; primary purpose other. Start 2016-02-02 (actual); primary completion 2017-03-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention
Condition
Drug-eluting Stent
Intervention (Device)
Angiolite
Intervention (Device)
Xience
Lead sponsor
Cardiva2 S.L. (class: industry)

Record details

Record id
cardio:ct-nct03049657
Content hash
4b06938897f1b4f0d05d2ce671109a1f3a4520215f854266738a3446e298885b